Patients description.
| Clinical parameter | Healthy controls, n = 27 | UC, n = 16 | CD, n = 24 |
|---|---|---|---|
| Male/female, n | 14/13 | 9/7 | 12/12 |
| Age at enrolment, mean ± SD, yr | 69.5 (±12.31) | 40.75 (±13.3) | 39.61 (±7.37) |
| Disease duration, mean ± SD, yr | — | 8.8 (±4.8) | 10.5 (±6.21) |
| Smoking status, yes/no/ex | — | 2/13/1 | 3/19/2 |
| CD, n | |||
| L1 ileal | — | — | 10 |
| L2 colonic | — | — | 3 |
| L3 ileocolonic | — | — | 11 |
| L4 upper | — | — | 0 |
| B1 (not strict/not penetrating) | — | — | 6 |
| B2 (stricturing) | — | — | 13 |
| B3 (penetrating) | — | — | 5 |
| UC, n | |||
| E1 proctitis | — | 1 | — |
| E2 left-sided | — | 11 | — |
| E3 pancolitis | — | 4 | — |
| Concomitant therapy at enrolment | |||
| No therapy | — | 7 | 15 |
| Antibiotics, n | — | 0 | 1 |
| Mesalamine, n | — | 6 | 3 |
| Thiopurines, n | — | — | 5 |
| Corticosteroids, n | — | 3 | 2 |
| Anti-TNF | — | — | 2 |